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ABSTRACT
Prevalence of Mesenteric Vascular Disease in Coronary Artery Disease
Patients
Introduction
Atherosclerosis is a global phenomenon affecting the primarily the medium sized
arteries irrespective of the vascular bed. Hence the involvement of a vascular site
at one site predisposes involvement of another distant site. The prevalence chronic
mesenteric ischemia is often underestimated because of its non-specific
symptomatology. Patient related and physician related are responsible for the delay
in the diagnosis till the stage of bowel infarction when there is high morbidity and
mortality. Paucity of studies on the natural course of disease further aggravates the
situation. Given the prevalence of coronary artery disease is very high, the same
population should also be predisposed for chronic mesenteric ischemia.
Materials and Methodology
110 patients, who underwent coronary angiogram for evaluation of suspected
coronary artery disease, were subjected to mesenteric angiogram at the same
sitting.
Results
Out of 110 patients, 7 had normal coronary study. The remaining 103 patients were
evaluated for synchronous mesenteric artery involvement. 44 out of 103 (42.7%)
had mesenteric involvement out of which 19 had indications for revascularization
(p<0.05). There was no difference between the genders. Higher age group (>65
years), diabetic and cases of known peripheral vascular disease were predisposed
for mesenteric artery involvement (p<0.05). Superior mesenteric artery was the
most common artery involved (72.2%). There was no correlation between the
severity of the coronary disease and mesenteric disease. However involvement of
left anterior descending artery had positive association with mesenteric artery
involvement.
Conclusion
The prevalence of mesenteric artery disease is common among the coronary artery
disease patients. The probability increases in elderly, diabetic and patients with
prior history of peripheral vascular disease. Further studies with longer follow-up
can help in understanding the natural course of the disease and thereby provide
better idea regarding the time of intervention.
Keywords
Mesenteric vascular disease, coronary artery disease, atherosclerosis, angiogram,
chronic mesenteric ischemia
 
1 
 
INTRODUCTION 
Mesenteric Ischemia 
Mesenteric artery ischemia ensues following reduced perfusion of the 
intestines. It is usually secondary to narrowing or blockage of one or 
more of the three mesenteric arteries, the major arteries that supply the 
gastrointestinal tract. Uncommonly ischemia can be result of reduced 
perfusion in the absence of occlusion of mesenteric arteries. While acute 
mesenteric ischemia has a dramatic presentation, chronic mesenteric 
ischemia has an insidious course. The fact that the natural course of 
chronic mesenteric ischemia is gradual and non-specific at early stages 
makes diagnosis of chronic mesenteric ischemia delayed by months or 
even years. Patient and physician related factors play a vital role in the 
failure to recognize the initial vague symptoms of mesenteric 
insufficiency invariably till the point of no return of bowel infarction 
when acute ischemia sets in (1). 
Anatomy 
The abdominal aorta measures 10 cms extending from T12 to lower 
one-third of the body of L4 (2). Given it is the principal artery supplying 
the multiple intra-abdominal organs, the large size of the branches 
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supplying the major abdominal viscera results in marked drop in aortic 
diameter through its descend. Within the 10 cm course the aorta which 
is 25 mm at the level of 11th rib becomes 19 mm in diameter at its 
bifurcation (3).  
The fact that, during embryogenesis, primitive gut lies anterior to the 
aorta makes the arteries that supply the gut ventrally placed. In contrast 
the arteries supplying the kidney and the gonads, retroperitoneal in 
origin, are laterally placed. 
The three principal arteries supplying the intra-abdominal 
gastrointestinal tract are celiac trunk, superior and inferior mesenteric 
artery (4). Anatomical variation of these vessels is common with celiac 
trunk being most prone. Recognition of this fact is important during 
major abdominal and laparoscopic surgeries to avoid catastrophes (5).  
Embryology 
Ventral segmental arteries emerge from the primitive ventral aorta. Most 
of these ventral segmental arteries regress with persistence of the 10th, 
13th and 21st branches forming the celiac axis, superior mesenteric artery 
and inferior mesenteric artery respectively. Deviations in the visceral 
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arterial anatomy results from disparity in the regression of the primitive 
ventral aorta and its segmental branches. 
Celiac Axis 
Celiac axis arises from the abdominal aorta at the level of L1. It is 
bordered superiorly by median arcuate ligament and inferiorly by the 
pancreas. The three branches from common trunk include the left 
gastric, splenic, and common hepatic arteries. However, multiple 
variations of the true “trifurcation” can exist. 
Superior Mesenteric Artery 
Superior mesenteric artery arises 1 centimeter distal to the celiac trunk 
from the aorta. It usually arises at an angle of 36–56 degrees with the 
aorta (6). At its origin the SMA lies superior to the uncinate process of 
the pancreas and the third portion of the duodenum. The inferior 
pancreatico-duodenal artery and middle colic artery are first two 
significant branches and play crucial role in collateral supply. The small 
bowel is supplied by right colic, ileocolic, jejunal and ileal branches as 
the SMA courses within the mesentery. 
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Inferior Mesenteric Artery 
Inferior mesenteric artery, the artery of the hindgut, arises at the level of 
third lumbar vertebra. It divides into sigmoidal branches and the left 
colic artery supplying the hindgut derivatives. 
Collateral Circulation 
The rich collateral circulation among the three visceral arteries make 
them relatively immune to ischemia. However absence of these make 
the gut highly vulnerable to infarction. Various named collateral 
branches have been described in the literature (7).  
Between Celiac axis and Superior Mesenteric artery 
• Rio Branco arcade – Right pancreatico-duodenal  
• Býhler arcade – Left pancreatico-duodenal 
Between Superior and Inferior Mesenteric artery 
• Arc of Riolan (meandering mesenteric artery) - middle and left colic arteries 
(8) 
• Marginal artery of Drummond - distal superior and inferior mesenteric 
arteries 
• Villemin arcade - proximal superior and inferior mesenteric arteries (9) 
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There are various other unnamed collaterals notable of which is multiple 
connections between superior rectal artery, which originates from the 
inferior mesenteric artery, and the middle and inferior rectal arteries that 
are branches of the internal iliac system.  
Pathophysiology of mesenteric ischemia 
The blood supply to the gastrointestinal tract is dynamic. In contrary to 
the blood supply of the important viscera like the brain, heart and renal 
which is vital and cannot be compromised at any condition, the blood 
supply to the intestines typifies the demand-supply physiology. After 
food ingestion, demand causes increased intestinal blood flow mediated 
by various chemicals. The increase in blood flow peaks at 30 to 90 
minutes after ingestion (10). The nature of the rise and sustenance of the 
increased blood supply depends on the size and the composition of the 
meal (11). On weight basis, fat produces the greatest hyperemia. The 
contribution of protein and carbohydrate to postprandial intestinal 
hyperemia though minimal can become significant in the presence of 
mesenteric insufficiency (12). The small bowel and pancreas are the 
major beneficiaries with minor increase to the stomach and colon (13). 
This is demonstrable by the marked increase in end-diastolic flow 
velocities in the superior mesenteric artery compared to the celiac axis. 
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The postprandial hyperemic response is attenuated in the presence of a 
hemodynamically significant arterial stenosis. This relative imbalance 
leads the accumulation of metabolites leads to postprandial pain or 
“mesenteric angina” (14). 
Causes of mesenteric ischemia 
Stenosis or occlusion of the mesenteric arterial circulation forms the 
predominant causative factor in the development of chronic mesenteric 
ischemia (15). Atherosclerosis is the leading cause chronic mesenteric 
ischemia. Other causes include fibromuscular disease, aortic dissection, 
isolated SMA dissection and neurofibromatosis. Collagen vascular 
diseases and autoimmune disorders such as rheumatoid arthritis, 
Takayasu's arteritis, giant cell arteritis, polyarteritis nodosa, Buerger's 
disease and systemic lupus have also been implicated in chronic 
gastrointestinal ischemia. Given the widespread involvement of the 
arterial system,  primary or secondary thrombosis of the superior 
mesenteric vein secondary to generalized hypercoagulable states or local 
pathologies such as abdominal malignancies; and inflammatory 
conditions, like pancreatitis account for <10% of all CMI cases (15). 
Apart from atherosclerosis the other etiologies collectively are less 
significant. However in the presence of appropriate clinical setting, 
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investigation needs to be performed to rule out these uncommon 
etiologies.  
Chronic Mesenteric Ischemia 
The true incidence of chronic mesenteric ischemia is difficult to 
ascertain because of its non-specific presentation at initial stages. The 
reported incidence is derived from various case series of treated patients 
which may not reflect at real picture (1). The underlying 
pathophysiology of chronic mesenteric ischemia is presence of adequate 
vascular supply at baseline and failure to achieve postprandial 
hyperemic intestinal blood flow. There are various factors that prevent 
the understanding the natural course of the disease. The rich collateral 
circulation of gastrointestinal tract provides adequate cushion for the 
vascular insufficiency to remain asymptomatic until advanced stage. 
Physician related factor plays an important role since the disease is not 
suspected in isolation leading to delay in the diagnosis. Once the disease 
is diagnosed, by demonstration of arterial occlusion and 
symptomatology, patients undergo revascularization precluding 
characterization of the course of the disease. All these factors make 
decision making tough as to enumerate guidelines regarding the 
management of chronic mesenteric insufficiency especially in 
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asymptomatic individuals. Eventually death results from inanition or 
bowel infarction. 
Abdominal pain is usually the presenting symptom often periumbilical 
with radiation to back. It is usually dull in character. It occurs 15 to 30 
minutes after eating and lasts 1 to 3 hours consistent with the underlying 
pathophysiology. The cause of the pain has been attributed to various 
ischemic mediators (16). The pain progresses from intermittent pain 
related with certain types or quantities of food to persistent, unremitting 
pain that likely forebodes bowel infarction. Physiological adaptation and 
patient adaptive strategies like diet modification causes partial relief. 
These strategies results in profound weight loss. The term ‘sitophobia’ 
denotes the condition where the patient fears food intake in order to 
avoid post prandial pain. The contribution of malabsorption to weight is 
found to be insignificant with inadequate nutritional intake being the 
primary cause (17). Patients can either have constipation due to food 
avoidance or may present with diarrhea. 
Physical examination is not particularly helpful in terms of identifying 
chronic mesenteric ischemia. Patients may have evidence of systemic 
vascular disease and abdominal bruits. The mere absence of systemic 
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vascular disease does not exclude the diagnosis since the vascular 
disease may be confined to the central aortic region (18). 
Acute Mesenteric Ischemia 
Acute mesenteric ischemia can result from two pathologies namely 
embolism and thrombosis.  
Embolism 
The most common cause of AMI is superior mesenteric artery 
embolization. Arterial emboli are responsible for 40% to 50% of cases 
of AMI (19). Intra-cardiac mural thrombus is the most common source. 
Proximal atherogenic thoracic or abdominal aorta are potential sources. 
SMA arising at a less acute angle from the abdominal aorta compared 
with the other mesenteric vessels, makes it vulnerable to receive the 
emboli. The usual site of lodging of the embolus is generally distal to 
the origin of the middle colic artery thereby sparing the proximal few 
centimeters of jejunum.  
Thrombosis 
Arterial thrombosis, after embolism constitutes for the next most 
common cause of mesenteric ischemia accounting for 20% to 35% of 
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cases (20). The thrombosis can be a result of a pathology affecting the 
vessel wall such as atherosclerosis or those affecting the blood such as 
hypercoagulable state. In the case of atherosclerosis given the gradual 
and progressive stenosis of the vessel, patients frequently have 
preexisting symptoms of chronic mesenteric ischemia. Review of 
literature of 45 observational studies by Schoots in 2004 involving 3692 
patients with acute mesenteric ischemia found that mortality from acute 
thrombosis of a mesenteric artery was higher compared to those 
suffering from acute embolism (77.4% vs. 54.1%) (21). The probable 
reason for this difference is attributed to the proximal location of the 
lesion resulting in more vessels occluded and consequently affecting 
larger segment of bowel. 
Non-occlusive Mesenteric Ischemia 
In the absence of a complete occlusion of the mesenteric arteries, 
intestinal ischemia can occur in low-velocity flow states, especially in 
the background of intestinal atherosclerotic disease. The most frequent 
primary etiology is cardiac dysfunction in the form of severe congestive 
heart failure and atrial fibrillation. It has to be borne in mind while in 
embolic occlusion mesenteric ischemia is due clot secondary to a clot in 
the left atrium whereas in non-occlusive mesenteric ischemia the 
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intestinal ischemia is secondary to reduced left ventricular output. 
Hepatic failure, hypovolemic shock, cardiovascular surgery, aortic 
incompetence and drugs are other causes (19). 
Investigations 
The investigation of the chronic mesenteric ischemia can be 
classifiedbroadly into the radiological demonstration of mesenteric 
vascular lesion and mucosal ischemia. The imaging can be further 
divided into non-invasive and invasive modalities. Conventional 
angiogram (Digital Subtraction Angiography) is the gold standard for 
the diagnosis of mesenteric lesion.  
The sensitivity and specificity of various investigative modalities are 
listed below 
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Investigations for anatomical lesion 
Conventional Angiogram (Arteriogram) 
Catheter 
The catheter type plays an important role in augmenting the 
angiographic image and evading injury to the vessel. They vary in 
shapes, sizes, and lengths. The other most important factor in deciding 
the choice of catheter is the site of hole at the end of catheter. It can be 
either end hole or multiple side holes, also called as flush catheter. Flush 
catheter, used in high flow large arteries, is meant for quick and uniform 
distribution of contrast agent at high injection pressures. While using 
end-hole catheters enables cannulation of remote arterial bed, injection 
of contrast at high pressure can cause formation of intimal flap in 
medium sized artery. The mode of injecting the contrast can be either 
hand injection or power injection.  
Contrast agent 
The principle of injecting contrast is to provide adequate visual contrast 
between the intravascular and the extravascular compartment. The 
timing of radiographic exposure to visualize the presence of contrast 
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material inside the vessel needs to be precise to avoid unnecessary 
exposure. Choice of the appropriate contrast agent needs to be decided 
taking into consideration two factors, namely, patient safety and 
imaging quality. Contrast agents have characteristic greater radio 
density than surrounding tissue making them appear darker on imaging. 
Agent considerably less radio dense than adjacent tissue, such as carbon 
dioxide (CO2) gas, can also provide sufficient contrast to image 
intravascular anatomic detail with little compromise on the image 
quality (22, 23). 
Conventional contrast agents are compounds with iodine being an 
integral part of the molecule. Iodine absorbs the x-ray photons and is 
responsible for the radiopacity of the contrast and thereby the 
visualization of the artery. Depending on dissociation of the contrast 
agent into anion and cation in a solution, they are categorized into ionic 
and non-ionic. 
In ionic iodinated contrast agents, the effective osmolarity is double the 
original osmolarity because two ions are formed when the agent 
dissolves. The benzene ring in the contrast are responsible for 
osmolarity. The osmolarity of these agents varies from 1500 to 
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1700 mOsm making them ominously more hyperosmolar than plasma 
(285 mOsm).  
Non-ionic contrast agents have considerably less osmolarity because of 
the aforementioned reason without affecting the radiopacity since the 
number of iodine atoms remain the same. Osmolarity can be further 
decreased by dimerization of contrast agent whereby two benzene rings 
are bonded to each cation resulting in formation of contrast agent with 
double the number of iodine atoms without increasing the osmolarity 
(ranging from 320 to 880 mOsm). The increased iodine atoms leads to a 
greater amount of x-ray photon absorption, and hence better 
arteriographic images. 
Toxicity of iodinated contrast agent 
The most common adverse effects are nausea, vomiting, and pain over 
the distribution of the specific vascular bed that is being studied. It is 
directly related to the osmolarity of the contrast agent and incidence is 
less with non-ionic contrast agents (24). Histamine release during 
contrast administration, ionic and non-ionic, is responsible for urticarial 
in minor cases and can cause laryngospasm at other end of spectrum 
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(25). Apart from the cardiac and hematological toxicity, nephrotoxicity 
is the most important complication.  
Contrast Induced Nephrotoxicity 
It ranks third among the causes of acute renal failure in hospitalized 
patients (26). Its presentation can vary from mild reversible rise in 
serum creatinine to end stage renal disease and even death. Certain 
population are at high risk of developing contrast induced nephropathy, 
the most important being pre-existing renal dysfunction (27). Other 
factors are increased age, severe left ventricular dysfunction, 
dehydration and hyperosmolar states (28). In these high risk patients, 
usage of minimal contrast media and pre-procedural hydration is 
necessary to avoid contrast induced nephropathy. However, in patents 
with normal renal function there seems to be little affect by the type of 
contrast agent and the contrast volume (29). In patients with end stage 
renal disease arteriogram can be performed with adequate precaution 
and probable need for dialysis post procedure.  
Non-iodine based Contrast Agents 
Other contrast agents that can be used in arteriogram are carbon dioxide 
and gadolinium. 
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Advantages of conventional angiogram 
The major advantages are high sensitivity and specificity for ostio-
proximal lesions and the good quality of projection of the peripheral 
mesenteric vasculature. The ability to delineate the pathological 
collateral circulation provides a road map when intervention is 
contemplated either endovascular or open. Real time imaging also helps 
in performing good quality imaging during inspiration and expiration, 
hence is of great importance in diagnosing celiac axis compression 
syndrome. The main drawbacks include the invasive nature, the 
potential contrast related complications and the inability to visualize the 
surrounding tissues. It also does not provide quantitative information 
about the mesenteric supply (30). 
Non-invasive imaging 
Radiography 
After the advent of Computed Tomography, there is no role for plain x-
ray with limited role for barium studies. The pathognomic feature of 
small bowel ischemia in barium studies include thickened valvulae 
conniventes and “thumbprinting”. There may be focal dilatation and 
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flattening of the mucosal folds due to the accumulation of blood in the 
submucosal layer. 
Doppler Ultrasound 
The diagnosis of the arterial stenosis is indirect derivative of the peak 
systolic flow velocity. Though the velocities are not affected in the 
initial stages of narrowing, peak systolic velocity of greater than  
200 cm/s and 275 cm/s in celiac axis and superior mesenteric artery 
respectively indicate more than 70% of stenosis of these vessels. Using 
these criteria the detection of significant lesions in celiac axis and 
superior mesenteric artery is 82% and 96% respectively (11). There are 
patient dependent and operator dependent factors which can pose 
difficulty in identifying the lesions. Body habitus, dilated bowel loops 
and previous surgeries are improtant patient related factors. Deep 
location of arterial orifices, tortuous proximal celiac axis make it less 
accessible for sonographic studies. Inappropriate placement of probe 
can lead to erroneous doppler angle and spectral waveforms. Despite 
these, given its high diagnostic accuracy in significant lesions when 
performed by experts, doppler study can be a useful screening tool in 
high risk individuals and initial investigation in patients with suspected 
chronic mesenteric ischemia rather than invasive angiogram. 
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Multidetector Computed Tomography Angiogram and Magnetic 
Resonance Angiogram 
By combining the virtue of non-invasiveness and advantages of 
conventional angiogram, computed tomography angiogram is being 
preferred in the evaluation of patients with acute and chronic mesenteric 
ischemia. In addition to the information provided by the conventional 
angiogram, CT detects tiny distal vascular segments and most 
importantly can characterise the plaque lesion identifying unstable 
plaques. The imaging of the fat, mesentery and omentum can help in 
identifying infarction. Magnetic resonance imaging is comparable to CT 
angiogram but cannot be performed in acute setting. 
Investigations for mucosal ischemia 
There is a necessity to prove intestinal ischemia even if the study of 
mesenteric vessels shows narrowing especially in single vessel disease. 
This not only confirms the diagnosis of mesenteric ischemia but also 
determines the outcome when intervention is planned. Even in a single 
vessel disease with greater than 50% stenosis presenting with abdominal 
symptoms, 60% truly have mucosal ischemia and will benefit from 
revascularizaion. Gastrointestinal tonometry is an established technique 
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to detect the mucosal ischemia. It involves the estimation of gastric 
mucosal carbon dioxide. In states of tissue hypoperfusion, acute shock 
or in chronic insufficiency, the carbon dioxide produced by the tissue 
during metabolism is not washed by the blood resulting in its 
accumulation.  This is a global phenomenon and the stomach being 
accessible organ by placement of nasogastric tube, gastric tonometry 
can be indirect evidence of perfusion to the rest of the gastrointestinal 
tract. Mensink during evaluation of 354 patients found the tonometry to 
have a sensitivity and specificity of 78-85% and 82-92% respectively in 
the detection of mesenteric ischemia (31). 
Based on the principle of inducible ischemia in cardiac patients similar 
tests have been evolved based on exercise induced and meal provoked. 
Even with postprandial tonometry, 4 out of 17 patients with mesenteric 
ischemia were missed (32). The reason for this is attributed to the fact 
that mucosal ischemia can last for short periods and entirely reversible 
in the intervening periods. 
Gastrointestinal tonometry combined with duplex ultrasound has been 
recommended as the best diagnostic strategy for individuals with 
suspected chronic mesenteric ischemia (33). Otte et al found screening 
with this combinedmodality would identify patients with symptomatic 
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ischemia and at the same time would have avoided 21% of unnecessary 
angiographies. 
Recent advances include visible light spectroscopy during endoscopy to 
ascertain tissue saturation and probable serum markers (34, 35). If these 
tests can be validated, they can provide easy accessibilty and may lead 
to a considerable increase in the diagnosis of chronic mesenteric 
ischemia. 
Coronary Artery Disease 
The importance of the disease process and its pandemic nature was 
probably not thought of when the first issue of the well renowned 
journal New England Journal Medicine and Surgery carried an article 
titled “Remarks on Angina Pectoris” by John Warren (36). As with most 
medical conditions, the treatment of the disease was based on 
assumptions rather than scientific basis. The situation though has 
improved but by no means has the problem of atherosclerotic coronary 
artery disease is nearing complete solution.  
With no investigations, there was significant delay in identifying the 
fact that occlusion of coronary artery by thrombosis results in the 
clinical features of angina pectoris and eventually the pathological 
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occurrence of myocardial infarction. This is evident by the fact that 
clinical description of angina by Heberden was in 1772; but the 
pathological identification of coronary thrombosis resulting in 
myocardial ischemia was described a century later by Ludvig Hektoen 
in 1879 (37, 38). Following years saw better understanding between 
clinicians and pathologist trying to explain the concept of myocardial 
infarction. The first major breakthrough in identifying the disease 
process in living individual  was done by Herrick when he  
used electrocardiography in five patients to diagnose myocardial 
infarction (39).  
With the increasing use of electrocardiogram and awareness on 
symptomatology of coronary artery disease, the focus shifted from 
identifying the onset of myocardial infarction to identifying risk factors 
of coronary artery disease. This was primarily driven by the fact that 
people belonging to the reproductive age group suffered a lot. The first 
well known study, based on the assessing the risk factors prevalent in 
the residents of Framingham, put forth that hypertension and elevated 
cholesterol levels were common in patients with ischemic heart disease 
and acute myocardial infarction. This finding formed an important link 
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in connecting the basic pathology of atherosclerosis and myocardial 
infarction 
Anatomy and Physiology of Coronary blood flow 
The heart is supplied by a group of epicardial vessels which are direct 
branches of aorta. They arise from the aortic root with the origin in 
relation to the sinus of Valsalva. Though there are three aortic sinuses, 
namely anterior, left posterior, and right posterior, there are only two 
arteries commonly present, left and right coronary artery. 
Left Coronary Artery 
The left coronary artery originates from the left coronary sinus in 
relation to the left cusp of the aortic valve. The common trunk called as 
left main artery has a very short course and divides to form the left 
anterior descending artery and the left coronary circumflex artery. 
Left Anterior Descending Artery (LAD) 
It courses in the interventricular sulcus from the aortic root toward 
cardiac apex. It generally crosses the acute margin of the heart, margin 
dividing the anterior surface of the heart from the inferior surface of the 
heart. At the end of the interventricular groove in the diaphragmatic 
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surface it forms an anastomoses with right system of the heart through 
posterior descending coronary artery. Throughout its course the artery 
gives off multiple perforating branches into the anterior part of the IVS. 
The first of these branches carries immense clinical importance in that it 
supplies the region of the bifurcation of the common atrioventricular 
bundle. 
Apart from these perforators the LAD typically provides several 
branches, which travel in an oblique course towards the left side and 
apex. It is for this reason they are aptly called as diagonal branches. 
They pass parallel to the superficial layer of myocardium in contrast to 
the perforators which pass perpendicular to the myocardium.  
Left Circumflex Artery (LCX) 
The left-circumflex coronary artery (LCX) courses in the left atrio-
ventricular groove to reach the posterior surface of left ventricle. During 
its course the left circumflex gives off obtuse marginal branches (OM). 
These branches predominately supply the anterior, anterolateral and the 
posterior surface of left ventricle.  
The termination of the left circumflex artery is variable. And the type is 
classified as dominance. When the left coronary circumflex artery gives 
 
24 
 
origin to the posterior descending artery and the atrioventricular node 
artery, the pattern of coronary artery distribution is classified as left 
coronary dominance. This more commonly seen in males. 
It should be borne in mind that the dominance is not decided by the 
blood supply of the entire interventricular septum but only the posterior 
part of the interventricular septum since the anterior 2/3rdsof the 
interventricular septum is invariably supplied by the left anterior 
descending artery. 
The type of coronary distribution where the right coronary artery gives 
of the posterior descending artery is called as right dominance. The 
clinical relevance of this dominance is due to the presence of 
anastomotic interconnections between the left and the right system of 
the coronary circulation and thereby providing a possible collateral 
coronary supply in the event of ischemic heart disease affecting any one 
of the coronary system.  
Right Coronary Artery 
It originates from the right coronary sinus of Valsalva. Its blood supply 
distribution usually includes the entire right atrium and the right 
ventricle. Right coronary artery is said to be “dominant” when the 
 
25 
 
posterior descending artery arises from the right coronary artery. During 
this circumstance, a part of the posterior left atrium and left ventricle, 
the posterior papillary muscle of the LV, and the A-V node also derive 
their blood supply from the right system. 
The conus artery is the first noteworthy branch of the right coronary 
artery. It frequently passes in anti-clockwise direction around the 
infundibulum. Arterial circle of Vieussens can be present when the 
conus artery anastomoses with a branch of the left anterior descending 
artery. It has also been found that in the elderly, the conus artery can 
arise from a separate aortic ostium. This variant is attributed to the 
growth of the aortic sinus, where the origin of the conus artery comes to 
be progressively integrated into the aortic valve. The knowledge of 
these variants is essential during surgical and endovascular intervention. 
The most common of these variants is an anomalous beginning of  
the main left or right coronary artery from the erroneous sinus of 
Valsalva (40). 
Sinoatrial Artery 
The next branch of the right coronary artery ascends along the anterior 
wall  of  the  RA  regularly  but  arises  from  the  deeper  side  of  the 
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RCA. It supplies the sinoatrial node. This occurs in about 40 percent of 
individuals 
Several branches supplying the anterior right ventricle are given off as 
the artery courses along the right atrioventricular groove. As the RCA 
crosses the margin to reach the diaphragmatic surface a right marginal 
branch called arteria margo acutus is given off. The right coronary 
artery coursing in the posterior right atrioventricular groove, near the 
crux, gives origin to posterior descending artery, atrioventricular nodal 
artery and a branch to the inferior surface of the left ventricle. 
Coronary Distribution and Anastomoses 
The epicardial arteries which course beneath the epicardium gives rise 
to the perforating branches which enter the myocardium. These 
perforators in turn give rise to small branches which arborize instantly 
to supply the outer two-thirds of the myocardium. The perforating 
arteries carry on, devoid ofadditional branching, to end in a large 
subendocardial plexus.  
Homocoronary, within the same system, and intercoronary anastomoses 
between the right and left system can be of pronounced significance in 
cardiac function and coronary artery disease. 
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Intercoronary anastomoses that commonly present are: 
• At the origin of the pulmonary conus, between the LAD and the 
conus branch of the RCA 
• At the interventricular groove, between the anterior (LAD) and 
posterior descending arteries (PDA) 
• On the diaphragmatic surface of the left ventricle, amongst 
terminal branches of the right coronary artery and the LCX 
• Within the substance of the interventricular septum, between 
perforating septal branches of the anterior and posterior 
descending arteries 
Coronary artery disease 
The spectrum of clinical presentation of coronary artery disease varies 
from asymptomatic individuals to sudden cardiac arrest (41).While the 
two extremes are difficult to detect or treat, it is the intervening phase of 
the disease process which forms the crucial period of effective 
intervention. The demand supply mismatch during episodes of ischemia 
causes momentary derangement of the mechanical, biochemical, and 
electrical functions of the myocardium. The tendency for coronary 
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atherosclerosis to be focal results in asymmetrical ischemia. Myocardial 
pump function can be altered due to ventricular contractility 
disturbances which might be in the form hypokinesia, dyskinesia or 
akinesia.  
While the gradual occlusion of the coronary vessels is associated with 
episodes of ischemia, an acute subtotal or total occlusion of coronary 
vessel is accompanied by instant failure of myocardial activity. There is 
a differential level of ischemia within the cardiac layers with the 
subendocardium being most affected. The involvement of the 
ventricular myocardium causes transitory left ventricular failure. Valve 
dysfunction can occur if the papillary muscles are involved in ischemia. 
The duration of insufficiency becomes important. While transient 
ischemia causes angina pectoris, prolonged periods can result in 
myocardial necrosis and scarring.  
Anginal pain is characterized by crescendo-decrescendo pattern lasting 
less than 5 minutes and radiating to either shoulder or arms. It is usually 
precipitated by exertion or emotional disturbance. Exertional angina is 
typically relieved by rest and sublingual nitroglycerin. The physical 
examination is unremarkable in patients with stable angina during the 
angina-free period. The patients can have stigmata of atherosclerosis 
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like xanthelasmas or nicotine staining indicating smoking habit. Barring 
C-reactive protein, laboratory investigations are not of much value in 
ischemic heart disease. 
12-lead electrocardiogram is the initial investigation of choice though it 
may be normal when recorded at rest in patients with typical angina 
pectoris. Though changes in electrocardiogram can suggest ischemic 
heart disease they are non-specific. The changes that can accompany 
ischemic heart disease are repolarization abnormalities, interventricular 
conduction defects and cardiac rhythm disturbance. Electrocardiogram 
changes suggestive of old myocardial infarction definitely indicate an 
underlying coronary artery disease. 
Echocardiography evaluates the left ventricular ejection fraction in 
patients with coronary artery disease. Affectation of ventricular 
myocardium results in both global and regional wall motion 
abnormalities of the left ventricle. In latent cases electrocardiogram and 
echocardiogram done before and after exercise can make evident the 
signs of ischemia. 
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Management of coronary artery disease 
The initial line of management is lifestyle modification and 
pharmacotherapy which are combined together to treat the various 
cardiovascular risk factors such as hypertension, hyperglycemia, 
dyslipidemia and obesity. Failure of these approaches, intervention is 
required, percutaneous or surgery, which are based on identification and 
removal of the stenosis(42). 
Coronary Angiogram 
Coronary angiogram demonstrates the lumen of the coronary arteries 
and hence detect coronary artery stenosis or occlusion. The test however 
is not suitable for evaluating the arterial wall and characterize the plaque 
if present. This gives way for false negative results when atherosclerotic 
lesion that does not intrude on the lumen may go hidden.  
Indications of coronary angiography 
Patients with Stable Ischemic Heart Disease, who have survived sudden 
cardiac death or potentially life-threatening ventricular arrhythmia 
should undergo coronary angiography to assess cardiac risk (43).  
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Patients with SIHD who develop symptoms and signs of heart failure 
should be evaluated to determine whether coronary angiography should 
be performed for risk assessment(44). 
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REVIEW OF LITERATURE 
Pathology of atherosclerosis 
The pathological process of atherosclerosis is a multifactorial entity 
predominately affecting the large and medium- sized arteries. The 
process which is now believed to start from infancy gradually increases, 
eventually compromising the vascular lumen. This vascular 
insufficiency leads to the dysfunction of the organs whose blood supply 
is compromised (45). The location of atherosclerotic plaques in the 
mesenteric circulation is characteristically at the ostium. These lesions 
are thought to be primary extensions of progressive atherosclerosis of 
the anterior aortic wall (15). 
Chronic mesenteric ischemia is a disorder posing diagnostic challenge 
and often the recognition is delayed till the setting of acute on chronic 
mesenteric ischemia which is associated with high mortality and 
morbidity. The delay in identification of the disorder by treating 
physician and the need for confirmation of the disorder by an invasive 
test, angiogram, form an important component of the eventual delay 
(33). With the advent of non-invasive screening tests like duplex 
scanning, serum markers and visible light spectroscopy, the diagnosis of 
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chronic gastrointestinal ischemia can be made at an earlier stage. Since 
bowels need not suffer from ischemia even in the presence of stenosis, 
demonstration of the mucosal ischemia is necessary for the diagnosis of 
mesenteric ischemia. Gastrointestinal tonometry is probably the only 
modality that demonstrates physiological changes that accompany 
actual ischemia. It involves the measurement of luminal PCO2 in 
comparison to arterial PCO2 and can detect early stages of vascular 
insufficiency. 
Poly-vascular atherosclerotic disease 
Though the presence of the global process should affect the vascular 
beds throughout the body, there is heterogeneity in their occurrence. 
This is hypothesized to be due to differential risk factor proﬁles for the 
various predilection places (45).This has grave implications on the 
management of these vascular diseases, since failure to identify and 
treat a co-existing vascular lesion at another site might significantly alter 
the prognosis.  
The medical management of atherosclerotic vascular disease is 
essentially the same involving cessation of smoking, lifestyle 
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modification, statins, antiplatelet agents, glycemic and blood pressure 
control.  
The largest study, to date, directed to identify coexisting lesions in 
known coronary artery disease patients is from Imori et al in January 
2013 from Japan. The study included 1734 patients who underwent 
diagnostic angiogram for suspicious coronary artery disease between 
September 2010 and July 2011. The carotid artery and the renal artery 
involvement were identified by means internal carotid artery duplex 
scanning and renal artery Doppler study respectively. The involvement 
of the peripheral arterial disease in the lower limb was determined by 
ankle-brachial index measurement using continuous wave Doppler 
probe. 1253 patients were confirmed to be having coronary artery 
disease. 24% of the studied population had more than one site involved 
with atherosclerotic lesion thus vindicating the rationale behind the 
study. The prevalence of carotid artery, renal artery and lower limb 
peripheral artery in patients with coronary artery disease was found to 
be 7%, 9% and 16% respectively. Involvement of any two sites was 
found in 7% and all three sites in 0.8% of studied population. The study 
put forth various independent risk factor for each vascular bed among 
the common cardiovascular risk factor. With respect to coronary artery 
 
36 
 
disease, single vessel disease was not significantly associated with 
atherosclerotic lesions at other site. The presence of left main disease 
was found to  be an independent risk factor for carotid artery, renal 
artery and lower extremity peripheral artery (46). 
Chronic mesenteric Ischemia in known atherosclerosis 
Chronic gastrointestinal ischemia is another extra-cardiac manifestation 
of atherosclerosis. Very few studies have compared the prevalence of 
mesenteric vascular diseases and the relationship with classical 
cardiovascular risk factors. Consensus has not been arrived at, since 
these studies are plagued by differential age distribution and small study 
population. Another important drawback in majority of these western 
based studies is that they were conducted in patients who underwent 
revascularization which may not be a true reflection of the mesenteric 
vascular disease.  
After an ischemic episode event at any site, there is high absolute risk 
for a recurrent ischemic event in the same or in any other vascular  
bed (47). Similarly, poly-vascular disease patients on comparison with 
mono-vascular disease patients have a doubled risk of cardiovascular 
related mortality (48). 
 
37 
 
In an analysis of 195 patients, atherosclerotic chronic gastrointestinal 
ischemia belonged to upper age group and were more often smokers 
with positive family history. They suffered from profound weight loss 
when compared to the control group (49).  
Need for revascularization 
Indication for revascularization has undergone dramatic changes in the 
last two decades. Generally fraught with high morbidity and mortality in 
the past, the open surgical revascularization, is being gradually being 
replaced by endovascular approach as the primary modality of 
revascularization. The high prevalence of the atherosclerotic lesion to 
involve the ostio-proximal segment of the mesenteric arteries and short 
segment involvement makes them accessible through endovascular 
approach (50). Revascularization is mandatory once the patients develop 
symptoms in order to prevent bowel infarction (51). The factors that are 
crucial in the decision making regarding revascularization include 
suitable anatomy, life expectancy and nutritional status. Apart from 
these, if procedures are planned for aneurysmal disease of the aorta and 
in presence of total stump occlusion, then open procedures are the 
treatment of choice (52). The following provides a useful algorithm for 
decision making regarding the type of revascularization. 
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The controversy lies in the treatment of asymptomatic individual. 
Though it was considered that intervention in asymptomatic individual 
is not warranted, better understanding of the natural history of the 
chronic mesenteric ischemia has seen changing concepts in this field.  
The rationale for this concept stems from the fact that nearly 50 % of 
mesenteric ischemia patients have acute infarction as their first 
manifestation (53, 54).  
Screening of asymptomatic elderly (>65 years) Americans in 2006, 
based on Doppler flow ultrasound-derived criteria showed that 17.5% of 
 
39 
 
the participants had critical mesenteric artery stenosis. On follow-up for 
more than 6 years none of them developed symptoms or intestinal 
infarction related mortality (55). In contrast, an arteriography based 
study by Thomson et al in 1998 found 82 of 980 asymptomatic 
individuals having at least one artery stenosis by more than 50%. They 
reported that 4 of 15 patients with significant stenosis affecting all three 
arteries developed mesenteric ischemia during a mean follow-up of                
2.6 years (53). 13 out of 15 patients with triple vessel disease developed 
abdominal pain or died during six year follow-up. Thus 
revascularization has to be considered in patients with known 
cardiovascular risk factors with significant triple-vessel disease even if 
the patient is asymptomatic. The fact that 15% to 50% of individuals 
presenting with acute mesenteric ischemia do not have any antecedent 
warning signs underlines the significance of early intervention (56). 
Hence asymptomatic individuals with significant stenosis of mesenteric 
vessels are candidates for endovascular intervention. 
Though revascularization procedures have evolved, there is still 
significant morbidity and mortality associated these procedures and 
these have to be carefully weighed against risk of mesenteric ischemia 
in asymptomatic individuals.  
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AIM   &  OBJECTIVES 
Aim 
To study the prevalence of mesenteric vascular disease in ischemic heart 
disease patients 
Objectives: 
To assess the symptomatology of mesenteric vascular disease 
To assess risk factors for atherosclerotic mesenteric vessel disease 
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MATERIALS AND METHODOLOGY 
Place of study: 
Govt. Stanley Medical College and Hospital, Chennai 
Duration: 
 January 2013 to June 2013 
Study design: 
Prospective observational study 
Inclusion criteria: 
Patients with suspected ischemic heart disease admitted for coronary 
angiogram 
Exclusion criteria: 
1. Patients with normal coronaries on angiogram 
2. Patients with elevated renal parameters 
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Methodology: 
Study of 110 consecutive patients with suspected ischemic heart disease 
admitted for coronary angiogram in the Department of Cardiology from 
January 2013 to June 2013. After obtaining informed consent, patients 
were enrolled for the study.  
A detailed history taking, with emphasis on the risk factors of 
atherosclerosis and abdominal symptoms was done followed by 
complete clinical examination. Allen test was performed to confirm the 
patency of the palmar arches.  
Patient was subjected to basic investigation and if renal parameters were 
normal, then patient was subjected to angiogram. Echocardiogram was 
performed as a part of cardiac evaluation. 
Patient preparation included administering Inj. Tetanus Toxoid if 
indicated, Inj. Lignocaine test dose and preparation of both wrist and 
groin.  
Procedure 
• Pre-procedure hydration maintained by administration of 
intravenous fluids 
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• Right radial artery was the preferred site of catheterization.  
• Local anesthesia administered at the local site.  
• Catheterization was done by Seldinger technique. 
• To prevent catheter clot formation - fluid containing Inj. Heparin 
500 IU diluted in 1 litre of NS was used for flushing 
• Coronary angiogram was performed 
• If coronary arteries were involved, then mesenteric angiogram 
was done 
• Selective cannulation of the three mesenteric arteries was done, 
and angiogram performed in two views - antero-posterior and 
lateral views 
• After the procedure, compressive dressing was applied 
• During the procedure, patient ECG, pressure and oxygen 
saturation was continuously monitored. 
• Patient was watched for anaphylactic reaction and contrast 
induced nephrotoxicity 
• Generally patient was discharged after 24 hours 
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Patients were followed up for 3 months with symptoms. 
If patient had lesions significant enough to warrant revascularization, 
they were advised to undergo intervention. (Only one patient underwent 
endovascular revascularization). 
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TABLES 
Table 1 Demographic Characteristics of study population 
 All (n=103) Mesenteric 
vascular 
disease 
(n=44) 
No 
Mesenteric 
vascular 
disease 
 Age 56.31 60.63 53.08 
Gender (M/F) 66/37 24/20 42/17 
Abdominal Symptom (Y/N) 26/77 19/25 7/52 
Diabetes Mellitus (Y/N) 41/62 29/15 12/47 
Hypertension (Y/N) 23/80 10/34 13/46 
Known Ischemic heart Disease 
(Y/N) 
23/80 13/31 10/49 
Peripheral Arterial Disease (Y/N) 21/82 19/25 2/57 
Dyslipidemia (Y/N) 32/71 15/29 17/42 
Smoking (Y/N) 40/63 20/24 20/39 
Alcohol (Y/N) 33/70 14/30 19/40 
BMI 
(Underweight/Normal/Overweight) 
8/46/49 6/29/9 2/17/40 
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Table 2 Mesentery artery-wise involvement 
Mesenteric artery Involvement 
Celiac 22 
SMA 39 
IMA 15 
 
Table 3 Coronary artery-wise involvement 
Coronary Artery Involvement 
RCA 52 
LAD 76 
LCX 63 
 
Table 4 Need for Revascularization in mesenteric arterial involvement 
 Mesenteric artery  
involvement 
P value 
Need for 
Revascularization 
Yes 18 
<0.01 No 26 
Need for Open 
Revascularization 
Yes 12 
0.5 No 32 
Significance at P < 0.05. Chi-Square test  
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Table 5 Mesenteric vessel involvement with epidemiological factors 
Parameter Classification Patients with 
Mesenteric artery 
involvement 
P- Value 
Age < 65 years 19 
< 0.01 
≥ 65 years 25 
Gender Male 24 
0.08 Female 20 
Symptomatic Yes 19 
<0.01 No 25 
Smoking Yes 20 
0.3 No 24 
Alcohol Yes 14 
0.9 No 30 
Significance at P < 0.05. Chi-Square test 
 
Table 6 Significant clinico-biochemical parameters in mesenteric artery 
involvement 
Parameter Classification Patients with 
Mesenteric artery 
involvement 
P- Value 
BMI < 25 35 < 0.01 
≥ 25 9 
Serum albumin < 3.5 20 < 0.01 
≥ 3.5 24 
ESR Elevated 27 <0.01 
Normal 17 
Significance at P < 0.05. Chi-Square test 
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Table 7 Co – morbidities with mesenteric artery involvement 
Co – Morbid 
Disease N Odds Ratio 95% CI 
Diabetes Mellitus 
29 
7.57 3.11 - 18.42 
15 
Hypertension 
10 
1.04 0.40 - 2.65 
34 
Known Ischemic 
heart disease 
13 
2.05 0.80 - 5.25 
31 
Peripheral 
Vascular Disease 
19 
21.66 4.68 - 100.13 
25 
Dyslipidemia 
15 
1.27 0.51 - 2.96 
29 
 
Table 8 Co - Morbidities with need for revascularization 
Co – Morbid 
Disease 
N Odds Ratio 95% CI 
Diabetes 
Mellitus 
11 
2.47 0.89 - 6.82 8 
Hypertension 
4 
0.91 0.27 - 3.07 15 
Known 
Ischemic heart 
disease 
9 
4.50 1.54 - 13.09 10 
Peripheral 
Vascular 
Disease 
8 
3.97 1.34 - 11.76 11 
Dyslipidemia 
5 
0.75 0.24 - 2.30 14 
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Table 9 Presence of Mesenteric artery disease with number of coronary artery 
involvement 
Coronary Artery 
involved 
Mesenteric arterial disease 
 P value 
Yes No 
One 12 25 
0.13 Two 19 25 
Three 13 9 
Significance at P < 0.05. Chi-Square test 
 
Table 10 Specific coronary artery with mesenteric artery disease 
Coronary 
Artery  
Frequency Mesenteric arterial 
disease 
 
P value 
Yes No 
RCA 52 22 30 0.9 
LAD 76 37 39 0.04 
LCX 63 30 33 0.2 
Significance at P < 0.05. Chi-Square test 
 
Table 11 Specific Coronary Artery with need for revascularization 
Coronary 
Artery 
Involvement Need for Intervention P- Value 
RCA 52 11 41 0.61 
LAD 76 16 60 0.38 
LCX 63 15 48 0.11 
Significance at P < 0.05. Chi-Square test 
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Table 12 Specific mesenteric artery with need for revascularization 
Mesenteric artery Involvement Need for 
revascularization 
P- Value 
Yes No 
Celiac 22 10 12 < 0.01 
SMA 39 15 24 < 0.01 
IMA 15 7 8 < 0.01 
Significance at P < 0.05. Chi-Square test 
 
Table 13 Specific Mesenteric artery with need for surgical intervention 
Mesenteric artery Involvement Need for Surgical 
Intervention 
P- Value 
Celiac 22 9 13 < 0.01 
SMA 39 11 28 < 0.01 
IMA 15 7 17 < 0.01 
Significance at P < 0.05. Chi-Square test 
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CHARTS  
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IMAGES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 Collateral network in Mesenteric blood supply 
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Figure 2 Blood Supply of the heart 
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Figure 3 Dr. Sven Ivar Seldinger (1921–1998) 
 
 
Figure 4 Seldinger technique 1. Insertion of needle. 2. Introduction of 
guidewire. 3. Removal of needle. 4. Advancement of dilator over the guidewire. 
5. Advancement of catheter over guidewire. 6. Removal of guidewire. 
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Figure 5 B-Mode study of Mesenteric Vessels 
 
 
Figure 6 Doppler study of Mesenteric vessels 
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Figure 7 Computed Tomography of Superior Mesenteric Artery (SMA) - MIP 
view 
 
Figure 8  Computed Tomography of Superior Mesenteric Artery (SMA)-VR view 
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Figure 9 Acute Embolic Mesenteric ischemia - the proximal jejunum is spared 
 
 
Figure 10 Acute thrombotic mesenteric ischemia 
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Figure 11 Characteristic clinical feature of patient with chronic mesenteric 
ischemia 
 
 
Figure 12 Pneumatosis Intestinalis in CT abdomen 
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Figure 13 Superior Mesenteric artery angioplasty 
 
 
Figure 14 Post Procedure 
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 Figure 15 Pre and Post Procedure angioplasty  
 
 
Figure 16 Mechanism of Angioplasty and Stenting 
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Figure 17 Various procedures for open revascularization 
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Figure 18 Patient I - Critical Celiac axis stenosis with post-stenotic dilation 
 
 
Figure 19 Patient I - LAD ostio-proximal critical lesion with distal LAD 
involvement 
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Figure 20 Patient II - Common Origin of Celiac axis and Superior Mesenteric 
Artery - No stenosis 
 
 
Figure 21 - Patient II - Distal left main - 80% stenosis, Proximal Left 
Circumflex Artery - 90% stenosis, Proximal Right Circumflex Artery - 70% 
stenosis 
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Figure 22 - Patient III - AAA with Complete occlusion of Celiac axis and 
superior mesenteric artery origin - AP view 
 
Figure 23 - Patient III -AAA with Complete occlusion of Celiac axis and 
superior mesenteric artery origin - Lateral View 
Right Renal 
 
Left Renal 
 
Right Renal 
 
Left Renal 
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Figure 24 - Patient III - Dilated Collateral arising from Inferior Mesenteric 
Artery 
 
 
Figure 25 - Patient III - Retrograde filling of Celiac Axis and Superior 
Mesenteric Artery 
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Figure 26 - Patient IV - 90% Ostial stenosis of Celiac Axis and 30% stenosis of 
Proximal Superior Mesenteric Artery 
 
 
Figure 27 - Patient IV  - Post CABG - Patent Arterial Graft (Left internal 
thoracic artery to LAD) , Diffuse disease of LCX 
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RESULTS 
From January 2013 to June 2013, a total of 110 patients underwent 
coronary angiogram for suspected ischemic heart disease in the 
Department of Cardiology at Govt. Stanley Medical College, Chennai.  
7 patients were found to have normal coronary study and were excluded 
from the study. 103 patients were included for further analysis. 
Mesenteric angiogram revealed 42.7% (n=44) to have mesenteric 
vascular disease and 57.3% (n=59) with no mesenteric involvement. 
The mean age of the population under study was 56.31 years with 
patients with and without mesenteric vessel involvement being  
60.63 years and 53.08 years respectively. 64% (n=66) were males and 
36% (n=37) were females. Only 26 (25%) patients had abdominal 
symptoms with weight loss being the major symptom. 7 out of these  
26 had no evidence of mesenteric vascular disease. The prevalence of 
diabetes mellitus, hypertension, known ischemic heart disease and 
peripheral arterial disease among the study population was 40%, 22%, 
22% and 20% respectively. Among those with mesenteric arterial 
involvement 70% were diabetic and 43% had prior history of peripheral 
arterial disease.  
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With respect to the coronary arteries the prevalence of single vessel, 
double vessel and triple disease was 36%, 43% and 21% respectively. 
Left Anterior descending artery was the most common involved 
coronary artery and affected in 73% (n=76) of the study population. 
Isolated left anterior descending artery affectation was present in  
19 patients with isolated left circumflex and right coronary artery 
involvement in 14 and 5 patients respectively. 
The prevalence of single vessel mesenteric disease and multivessel 
disease among the study population was 19.4% and 23.3% respectively. 
Stenosis of superior mesenteric artery was present in 89% (n=39) of 
those with mesenteric involvement and 38% of the study population. Of 
these 39, isolated superior mesenteric artery stenosis was present in  
16 patients and part of multi-vessel disease in 23 patients. The next 
common artery to be involved was celiac axis followed by inferior 
mesenteric artery in 22 and 15 patients respectively.  
There was a strong association between presence of symptoms and 
superior mesenteric artery involvement. 
Among the epidemiological factors age (65 years) and presence of 
abdominal symptoms were associated with prevalence of mesenteric 
vessel disease (p<0.05). Patients belonging to the underweight and 
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normal category was positively associated with mesenteric disease. 
With respect to the investigation, only serum albumin and erythrocyte 
sedimentation rate correlated with involvement of the mesenteric 
vessels. 
The severity of the coronary disease was not associated with mesenteric 
vessel disease. However involvement of Left anterior descending artery 
indicated mesenteric vascular disease (p=0.04).  
Among the 44 with mesenteric vascular disease, 18 fulfilled the criteria 
for revascularization of which 12 for open surgical revascularization 
(p<0.01). There was no significant association with a particular 
coronary artery with the need for revascularization. 
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DISCUSSION 
Atherosclerosis is a generalized phenomenon affecting all the vessels of 
the body especially the large and medium sized arteries. From being 
considered primarily a defect in fat metabolism, the theory behind its 
occurrence has evolved into an inflammatory process (57). Chronic 
inflammation is considered an essential component in the evolution of 
the atherosclerotic plaque starting from initiation to the eventual rupture 
of plaque (58). There have been reports of link between possible 
pathogens and the occurrence of atherosclerosis. The commonly 
implicated infectious agents include Chlamydia pneumonia and 
cytomegalovirus and their association is reinforced by their detection in 
human atherosclerotic lesion (59). The theory of atherosclerosis as being 
thought of inflammatory process has profound impact on the 
management of the disease. Though cannot be considered as substitute 
to traditional risk assessment, inflammatory markers, may prove to be 
useful adjuncts to determine the intensity of intervention (57). By the 
same concept, putative anti-inflammatory inhibitors like statins, ACE 
inhibitors, aspirin, and omega-3 fatty acids could have increased role. 
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Clinical studies have advocated that a state of “panvascular” active 
inflammation exists (60). In fact Lombardo et al in 2004 found that the 
not only was there a presence of concurrent atherosclerotic lesion in 
carotid artery in unstable angina patients but, the nature of coronary 
plaque instability correlated with carotid artery plaque instability. These 
observations have significant implications for understanding  
the mechanisms of acute widespread atherothrombotic 
plaque inflammation (61).  
Age 
Age plays a pivotal role in the process of atherosclerosis. It is associated 
with signiﬁcant change in the physiological properties of the afﬂicted 
vessel (62). Increasing age is accompanied by marked intimal 
thickening and medial thinning of the peri-renal aorta (63). The age-
related increase in intimal thickness is more pronounced in the 
abdominal aorta compared with other sites (64). Study by Jarvinen et al 
found that the prevalence of arterial abdominal stenosis in subjects 
younger than 40 years was 6%, in contrast to 67% in subjects aged 
above 80 years (65). Screening of asymptomatic elderly Americans 
(mean age 77 years) by duplex ultrasound demonstrated 18% 
involvement of the celiac axis or the superior mesenteric artery (66). 
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Roobottom et al found that in asymptomatic individuals the prevalence 
of isolated CA stenosis was 3% of subjects under 65 years and 18% in 
subjects above 65 years of age (67). This was concordant with our study 
with the mean of age of subjects with and without mesenteric 
involvement being 60.63 years and 53.08 years respectively. There was 
a significant difference between age groups <65 years and ≥ 65 years 
(p<0.01). 
Gender 
The involvement of aortic atherosclerosis in pathological specimen 
suggests that the advancement of atherosclerotic process occurs at a 
younger age in women concurring with clinical observation of 
peripheral arterial disease occurs earlier in females (63, 68). The 
preponderance to male in atherosclerotic disease is confined to the 
coronary vessels (45, 69). Veenstra et al in a study of 376 patients with 
chronic splanchnic ischemia found 74% of the affected population to be 
females (70). In our study there was no significant difference between 
the two genders with respect to mesenteric vascular disease or 
symptomatic mesenteric disease (p=0.08 & p=0.8). The difference is 
possibly due to the fact that the study population included patients who 
underwent coronary artery evaluation which is more common in males. 
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Mesenteric artery disease 
In 1981, Croft et al found in 203 autopsies that mean stenosis of celiac 
axis, superior mesenteric artery and the inferior mesenteric artery to be 
21.9%, 27.3% and 30.5% respectively (71). In another series examining 
the asymptomatic elderly also showed out of 553 elderly, 97 had critical 
mesenteric arterial occlusion with isolated celiac axis and superior 
mesenteric involved in 83% and 5% respectively (55). In 45 patients 
who underwent stenting for symptomatic mesenteric arterial occlusion, 
19 patients for superior mesenteric artery stenting, 8 for celiac axis 
stenting and 10 for both the vessels (72). The above studies probably 
indicate that there is high prevalence of celiac axis stenosis in the 
asymptomatic individuals whereas in symptomatic patients the superior 
mesenteric artery is the most common artery involved. The presence of 
abdominal symptoms suggestive of mesenteric insufficiency was 
significantly associated with presence of mesenteric vascular disease 
(p<0.01). Ischemic heart disease patients with abdominal symptoms 
were at 5 times more risk of having mesenteric vessel disease  
when compared to those without abdominal symptoms (OR = 5.64  
95% CI: 2.06-15.09). 
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Symptomatology 
The classical triad of symptoms of post prandial pain, weight loss and 
fear of food is seldom found. The fact that ischemic heart disease 
patients are on polypharmacy and have multiple co-morbidities makes it 
difficult for the treating physician and the patient to attribute vague 
abdominal symptomsat initial stages to mesenteric vascular 
insufficiency.  As discussed earlier, involvement of the superior 
mesenteric artery is proposed to be primarily responsible for the 
symptomatology given its high prevalence in symptomatic patients on 
the contrary to the involvement of celiac axis in asymptomatic 
individuals. Wilson et al found that clinically significant loss of weight 
had a strong correlation with superior mesenteric artery stenosis (55). 
Weight loss was the predominant symptoms occurring in all the 26 
symptomatic patients and classical triad present only in 4 patients. Of 
the 26 patients who had symptoms suggestive mesenteric insufficiency 
16 of them had involvement of superior mesenteric artery (p<0.01). 
Other abdominal symptoms such as vomiting and diarrhea were rarely 
present.  
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Co-morbid Diseases 
Diabetes mellitus 
One of the most important predisposing factor of atherosclerosis and 
cardiovascular disease, by corollary, plays a vital role in chronic 
mesenteric ischemia (31). The added insult to the intestinal blood supply 
by diabetic autonomic neuropathy exaggerates the gastrointestinal 
tract’s inability to increase blood supply during the post prandial period. 
Veenstra et al showed 21% of chronic gastrointestinal ischemia patients 
had diabetes mellitus. Our study not only found that diabetic patients in 
the background of coronary artery disease were at 7 times more risk of 
developing mesenteric arterial disease (95% CI : 3.11-18.42) but also 
had 2.5 times the risk of needing vascular intervention to treat the 
mesenteric disease (95% CI : 0.89-6.82). 
Hypertension and Dyslipidemia 
Classical risk factors for cardiovascular disease, hypertension and 
dyslipidemia, have been reported by various studies to be associated 
with chronic gastrointestinal ischemia (49). Sara et al found that 
atherosclerotic chronic gastrointestinal ischemia were more likely to be 
suffering from hypercholesterolemia and hypertension when compared 
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to the control group (31, 49). In a study based in Netherlands the 
prevalence of hypercholesterolemia and hypertension  was 53% and 
62% respectively (70). In our study the prevalence of hypertension and 
dyslipidemia in patients with mesenteric vascular disease was 22% and 
34% respectively (p>0.05). 
Peripheral arterial disease 
Being a process affecting large and medium sized arteries, vascular beds 
throughout the body are prone for affectation. This has been ascertained 
by various studies (70, 73, 74). Their strong association necessitates the 
screening for involvement of one vascular bed when the patient presents 
with atherosclerotic vascular insufficiency at one site. Carotid artery 
stenosis has been reported to range from 2-18% in asymptomatic 
screened population. However they can be as high 30% in high-risk 
population such as those with coronary artery disease (73). A study of 
1405 patients with coronary artery disease revealed 5% prevalence of 
concomitant severe carotid artery disease (> 70% stenosis). A similar 
involvement of the renal artery (>75% stenosis) was also found in 3987 
patients who underwent abdominal angiogram during coronary artery 
evaluation (74). On the same note, 9% of coronary artery disease 
patients had lower limb peripheral arterial disease and there was a 
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significant correlation to the extent of coronary artery disease (75). The 
reverse also holds good in that 59% of chronic mesenteric ischemia had 
atherosclerotic disease in other vascular beds (70). The past history of 
peripheral arterial disease was highly significant in our study with 
mesenteric vascular disease with a positive history predisposing the 
patient to 21 times the risk of having mesenteric vascular disease 
compared to negative history (95% CI : 4.68 - 100.13).  
Serum markers 
Identification of reliable serum markers for intestinal ischemia for 
chronic mesenteric ischemia would be of immense value as a non-
invasive diagnostic test since the only test to test mucosal ischemia, 
tonometry, is limited by its availability and patient-unfriendly nature 
(35). Various serum markers have been described for acute mesenteric 
ischemia including early markers like intestinal fatty acid binding 
protein, D-dimer and late markers like lactate dehydrogenase, C-reactive 
protein (76). Research has been directed identifying these biomarkers by 
inducing ischemia, such as post prandial period, to identify chronic 
gastrointestinal insufficiency. In our study we found serum albumin to 
be significantly associated with mesenteric vessel disease probably due 
to malabsorption rather than a marker of intestinal ischemia. 
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Mesenteric arterial disease 
On analyzing the 103 patients, 44 patients had involvement of 
mesenteric arterial disease among which 19 had abdominal symptoms. 
Superior mesenteric artery was the most common artery involved either 
in isolation or as combination with other vessel involvement. There is 
lack of consensus as to vessel commonly involved, with studies in 
asymptomatic individuals pointing towards celiac axis and those studies 
based on population subjected to intervention tending towards superior 
mesenteric artery involvement (55, 66, 77). 
Foley even suggested that revascularization of the superior mesenteric 
artery alone should suffice given its prominent role in symptomatology 
(78). This could be applied to our study population and gains clinical 
importance. Endovascular intervention for single mesenteric vessel, 
superior mesenteric artery, even in the presence of other mesenteric 
vessel involvement is feasible when angioplasty is planned for the 
coronary artery disease and can have good clinical outcome. 
Coronary Artery Disease 
There have been studies intending to find correlation of the coronary 
artery disease and arterial diseases at other locations. The largest of 
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these is by Imori et al involving 1734 patients. The study was aimed at 
finding co-existence of coronary artery disease with other 
atherosclerotic vascular lesions involving the carotid, renal and lower 
limb peripheral artery. The studied demonstrated that majority of 
patients with coronary artery disease and association of other vascular 
beds, especially multivessel coronary artery disease. They suggested 
proactive screening for synchronous atherosclerotic vascular lesion at 
other sites in multivessel disease and involvement of left main disease 
(46). The reason for predisposition for left main disease to have 
concurrent lesion at other vascular beds has been poorly understood.  
The left main coronary involvement is generally associated severe 
coronary artery disease in that 80% of these patients have multivessel 
coronary artery disease and 50% have right coronary involvement. 
Furthermore, at least total occlusion of one coronary artery was present 
in 50% of patients. All these factors make the left main involvement 
associated with unfavourable outcome (79). 
In our study the involvement of left anterior descending artery was 
associated with mesenteric vessel disease (p=0.04). The severity of the 
coronary disease, single vessel disease or multi vessel disease was not 
associated with mesenteric vessel involvement (p=0.14).  
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CONCLUSION 
The process of atherosclerosis is a generalized process sparing no 
vascular bed. However the variability of sequence and severity of 
affectation at various sites poses challenge with respect to screening of 
distant vascular beds at the time of diagnosis of atherosclerotic vascular 
disease at one site. 
Coronary artery disease is a pandemic disease and probably one of the 
first site to be involved in the process of atherosclerosis. Given the 
widespread awareness among the patients, well-formed guidelines for 
itsdiagnosis and treatment of coronary artery disease among the 
physician and the dramatic symptomatology, trend is towards detection 
at early stages and resulting in increased salvage of myocardium.  
On the other hand atherosclerotic process of other vascular beds such as 
carotid artery and renal artery can be screened by simple, non-invasive, 
reliable duplex scan in patients with high risk factors.  
Chronic mesenteric ischemia, if at all diagnosed, is identified at a late 
stage of the disease process. Lack of a simple reliable non-invasive tests 
in comparison to the gold standard invasive arteriogram prohibits the 
screening of high risk individuals. With recent studies highlighting the 
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reliability of non-invasive tests, single or in combination, would 
probably make the detection of mesenteric insufficiency at an earlier 
stage. Earlier there were reports that mesenteric arteries screening was 
unnecessary in asymptomatic individuals and results in unnecessary 
expenditure (55). However recent studies with better understanding of 
the natural course of the disease have been categorical with respect to 
need for intervention in asymptomatic individuals with significant 
mesenteric artery narrowing (53).  
Our study clearly demonstrates the presence of abdominal symptoms in 
coronary artery disease patients is strongly associated with mesenteric 
disease. Advanced age, presence of diabetes mellitus and peripheral 
arterial disease are useful predictors of mesenteric vascular disease. 
Though the severity of the coronary artery disease is not associated with 
occurrence of mesenteric disease, the involvement of left anterior 
descending artery should necessitate the physician to rule out mesenteric 
vessel involvement. 
Advances in the endovascular techniques, expertise and stents have seen 
the gap between a morbid open revascularization and relatively safe 
endovascular revascularization being narrowed with respect to their 
indication. Though the long term outcome of severe multivessel disease 
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is better with surgical revascularization, endovascular intervention has 
an important role in single vessel disease (51). The fact that superior 
mesenteric artery is considered as the primary culprit for the symptoms 
and revascularization of superior mesenteric artery alone may be 
adequate in treating chronic mesenteric insufficiency makes 
endovascular approach more attractive (78). Given the high prevalence 
of mesenteric vascular disease with or without symptoms in the 
background of atherosclerotic vascular disease at other sites, screening 
of the mesenteric vessel for involvement and also treating the same with 
endovascular intervention might increase the overall survival by 
reduction of acute mesenteric thrombosis. 
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LIMITATIONS 
Mucosal ischemia not confirmed by tonometry 
Follow-up period too short to assess the natural course of the disease 
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PROFORMA 
• Name :         sl. No: 
• Age /sex: 
• Address with contact number: 
 
• Ip no: 
• Date of admission:     Date of discharge: 
History of presenting illness: 
Cardiac Symptoms 
 Chest pain SOB Palpitation Syncope 
Onset     
Duration     
Progression     
Persistent/intermittent     
 
• Abdominal symptoms 
Weight loss  yes/no  Quantification 
Post prandial pain:  yes/no 
Fear of food  yes/no 
Nausea   yes/no Vomiting yes/no  
Constipation  yes/no Diarrhea yes/no 
Past history: 
DM  yes/no duration HT  yes/no duration 
IHD  yes/no duration PVD  yes/no duration 
Dyslipidemia yes/no duration 
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Personal history: 
Smoking    yes/no   Alcoholism yes/no 
Physical activity   low/moderate/high  
Family history:   yes/no 
Treatment history: antiplatelet/ hypolipidemic agents/ OHA/ 
insulin/antianginal 
Clinical examination:  
Anthropometry : 
BMI   - Under weight / Normal / Overweight / Obese 
Waist/Hip ratio - Low / Normal / High / Very High 
Heart Rate :   Blood Pressure :   Temperature : 
Investigations: 
Hb  RBS  
TC  BUN  
DC  S. 
creatinine 
 
ESR  S. bilurubin  
Platelet  AST/ALT  
Hba1c  S. protein  
Cholesterol  TGL  
HDL  LDL  
  
ECG    Chest x-ray   Abdomen x-ray 
Echocardiogram – LV dysfunction – none / mild / moderate / severe 
   RWMA – present / absent 
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Angiogram 
RCA  SMA  
LAD  Celiac  
LCX  IMA  
 
Follow up: 
  
 
97 
 
©õµøh¨¦ @|õ¯õÎPÎÀ S¸v@¯õmhUSøÓ 
ShÀ @|õ#  {PÌÄ £ØÔ¯  B#Ä 
 
 
B#ÁõÍº : hõUhº. Q. öPÍu® 
  •x{ø» £mh @©Ø£i¨¦ ©õnÁº. 
  AÖøÁ ]QaøŒ £mh£i¨¦ 
 
}[PÒ C¢u B#ÂÀ £[@PØP AøÇUP¨£kQÕºPÒ. C¢u 
B#ÂÀ £[@PØS®  •ßÚº, Cuß @|õUPzøu²®, •øÓPøÍ²® 
CuÚõÀ HØ£hUTi¯ ¤ßÂøÍÄPÒ H@uøÚ²®, }[PÒ AÔ¢x 
öPõÒÍ B#ÁõÍº  AÎUS® uPÁÀ ¤ßÁ¸©õÖ. 
Cu¯zvØS  Cµzu Jmh® uøh£mhuõÀ, Auß @Áø»£õk 
SøÓ¯ Áõ#¨¦ EÒÍx. AuÚõÀ ©ØÓ EÖ¨¦PÐUS Cµzu Kmh® 
SøÓ¯ Áõ#¨¦ EÒÍx.  
Sh¾US Cµzu Kmh® SøÓ¢x •ØÔ¾©õP uøh£k® @£õx 
ShÀ AÊQ £õv¨£øh¯ Áõ#¨¦ EÒÍx. AÆÁõÖ HØ£mh ¤ßÚº 
AuøÚ AÖøÁ ]QaøŒ öŒ#x  APØÔ, ªg]¯  Shø» CønUP 
AÁ]¯® HØ£k®.  
CÆÁõÖ ShÀ AÊQ £õv¨£øhÁuØS •ßÚ@µ, AuøÚ 
PshÔ¯ Bg]@¯õQµõ® öŒ#x Cµzu Kmh® SøÓ£õmøh 
PshÔ¢x, ShÀ AÊQ @£õÁøu uÂºUP, C¢u B#Ä  £¯ß£k® 
Gß£øu öu›ÂzxU öPõÒQ@Óß.  
uõ[PÒ   C¢u  B#ÂØS  Œ®©u®  öu›ÂUS®  £mŒzvÀ  C¢u  
£iÁzøu •Êø©¯õP £izx £õºzx •Ê©Úxhß 
øPö¯õ¨£ªk©õÖ @PmkUöPõÒQ@Óß.  @©¾®  C¢u B#ÂÚõÀ 
u[PÒ Eh¾U@Põ, ©ÚxU@Põ G¢uÂu EøÍaŒÀ HØ£hõx GßÖ® 
EÖv¯ÎUQ@Óß.  
C¢u B#Âß •iÄPÒ ©¸zxÁ Põµn[PÐUPõPÄ® 
©¸zxÁ PÀÂUPõPÄ® £¯ß£kzu¨£k®. C¢u B#Âß 
Œ¢@uP[PÐUS E›¯ •øÓ°À  ÂÍUP©ÎUP¨£mk,  u[PøÍ¨ 
£ØÔ¯ uPÁÀPÒ µP]¯©õP¨ £õxPõUP¨£k®.  
C¢u B#Â¼¸¢x G¨ö£õÊx @Ásk©õÚõ¾® uõ[PÒ 
GÆÂu  •ßÚÔÂ¨¤ßÔ²®,  GÆÂu  Œmh  ]UP¾®  CßÔ²®,  
Â»QU öPõÒÍ»õ®.  
C¢u B#ÂÀ £[@PØS©õÖ @PmkU öPõÒQ@Óß.  
 
|ßÔ, 
 
 
 
B#ÁõÍº øPö¯õ¨£®    @|õ¯õÎ°ß øPö¯õ¨£® 
hõUhº Q. öPÍu®     (ö£¯º) 
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©õµøh¨¦ @|õ¯õÎPÎÀ S¸v@¯õmhUSøÓ 
ShÀ @|õ#  {PÌÄ £ØÔ¯  B#Ä 
 
”¯ J¨¦uÀ £iÁ® 
 
ö£¯º  :    Á¯x :    EÒÎ¸¨¦ Gs. : 
 
 C¢u  ©¸zxÁ  B#Âß   ÂÁµ[PÒ  GÚUS  ÂÍUP¨£mhx.  
GßÝøh¯ Œ¢@uP[PøÍU @PmPÄ®. AuØPõÚ uS¢u 
ÂÍUP[PøÍ¨ ö£ÓÄ® Áõ#¨£ÎUP¨£mhx.  
 |õß CÆÁõ#ÂÀ ußÛaøŒ¯õPz uõß £[@PØQ@Óß. G¢u 
PõµnzvÚõ¾®, G¢u Chzv¾®, G¢u Œmh ]UP¾US® Em£hõ©À 
C¢u   B#Â¼¸¢x   Â»QU  öPõÒÍ»õ®  GßÖ®  AÔ¢x  
öPõs@hß.  
 |õß  B#Â¼¸¢x  Â»QU  öPõshõ¾®  B#ÁõÍº   
GßÝøh¯ ©¸zxÁ AÔUøPPøÍ¨ £õº¨£uØ@Põ AÀ»x 
E£@¯õQUP@Áõ Gß AÝ©v @uøÁ°Àø» GÚ AÔ¢x 
öPõÒQ@Óß. GßøÚ¨ £ØÔ¯ uPÁÀPÒ µP]¯©õP¨ 
£õxPõUP¨£k® Gß£øu AÔ@Áß.  
 C¢u B#Âß ‰»® QøhUS®  uPÁÀPøÍ²® £›@ŒõuøÚ 
•iÄPøÍ²®, B#ÁõÍº AÁº Â¸¨£zvØ@PØ£ GÆÂu©õPÄ® 
£¯ß£kzvU öPõÒÍÄ® Aøu ¤µ”›UPÄ® Gß •Ê©Úxhß 
Œ®©vUQ@Óß.  
 C¢u B#ÂÀ £[S öPõÒÍ J¨¦U öPõÒQ@Óß. GÚUS 
öPõkUP¨£mh AÔÄøµPÎß£i |h¢x öPõÒÁxhß 
B#ÁõÍ¸US Esø©²hß  C¸¨@£ß GßÖ® EÖv¯ÎUQ@Óß. 
Gß EhÀ |»® £õvUP¨£mhõ@»õ AÀ»x Gvº£õµõu  ÁÇUPzvØS 
©õÓõÚ @|õ#USÔ öuß£mhõ@»õ Eh@Ú Aøu öu›Â¨@£ß GÚ 
EÖv TÖQ@Óß.  
 C¢u B#ÂÀ GÚUS £[S öPõÒÍÄ®, ©ØÖ® AøÚzx 
£›@ŒõuøÚPøÍ²® ]QaøŒPøÍ²® @©ØöPõÒÍ |õß 
•Ê©Úxhß Œ®©vUQ@Óß.  
C¨£iUS, 
 
 
 
B#ÁõÍº øPö¯õ¨£®    @|õ¯õÎ°ß øPö¯õ¨£® 
hõUhº Q. öPÍu®     (ö£¯º) 
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1 Bhuvaneshwari 64 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 2 2 2 42 145 154 10.6 6800 25 3.6 7 86 28 0.8 0.7 25 28 4.7 1 1 1 1 1 1
2 Devarajan 47 1 2 2 2 1 2 2 2 2 1 2 2 1 2 2 2 2 2 2 2 1 2 40 130 145 10.8 7200 5 3.8 7.4 99 25 0.7 0.6 32 30 4.3 1 3 1 1 2 2
3 Fathima 65 2 2 2 2 2 2 2 2 1 1 2 2 1 2 2 2 2 2 1 2 2 2 45 125 150 115600 5 2.8 6.8 102 30 0.8 0.6 32 36 4.2 3 3 3 1 1 1
4 Kumuthavalli 65 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 1 2 2 3 3 50 150 125 11.65800 5 3.4 7.1 97 25 0.6 0.6 30 34 4.7 1 3 1 1 1 1
5 Mangalam 70 2 1 1 2 1 2 2 1 1 1 2 2 1 1 2 1 2 2 2 2 1 2 30 155 145 8.6 8600 20 3.4 6.5 124 25 0.6 0.7 60 80 3.3 3 3 3 3 3 1
6 Meenakshi 55 2 2 2 2 1 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 1 2 45 154 169 10.3 5200 10 2.8 6.5 11024 0.7 0.6 40 35 4.9 1 1 1 1 1 2
7 Rajendran 55 1 0 2 2 2 2 2 2 2 1 1 2 2 2 2 1 2 2 2 2 2 2 30 124 145 11.35600 12 2.9 6.5 120 22 0.6 0.7 34 32 3.8 1 3 3 1 3 1
8 Shanmugam 65 1 2 2 2 2 2 2 2 2 2 1 2 2 2 2 1 2 2 2 2 2 3 40 120 150 10.6 8400 10 3.6 7 96 21 0.6 0.7 35 31 4.3 3 3 1 1 1 1
9 Beena 45 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 1 2 2 2 3 50 130 150 10.4 4600 8 4 7.2 102 20 0.8 0.6 45 50 4 3 1 2 1 1 1
10 Ramanaiah 45 1 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 1 2 1 38 145 154 12.14900 5 3.7 7.1 100 24 0.5 0.5 24 26 3.9 3 2 1 1 1 1
11Sugurani 58 2 2 2 2 2 2 2 2 2 1 2 2 1 2 2 2 2 1 2 2 1 2 35 125 120 11.86500 8 3.5 7.2 95 24 0.5 0.6 28 30 4.5 1 1 2 1 1 1
12 Somarajan 56 1 2 2 2 2 2 2 2 1 2 2 2 2 1 2 2 2 2 1 1 3 3 48 150 164 10.5 4700 8 3.5 6.5 97 22 0.5 0.9 24 24 4 3 3 1 1 1 1
13 Sreekanth 45 1 2 2 2 1 2 2 2 2 1 2 2 1 2 2 2 2 2 1 1 2 1 40 120 150 11.55900 6 3.8 8 102 25 0.6 0.6 28 29 3.5 2 3 1 2 2 2
14 Swaminathan 72 1 1 1 2 2 2 2 2 2 1 1 2 1 2 1 1 2 2 1 2 1 2 48 101140 117800 12 2.5 6.9 123 28 0.8 0.6 24 28 3.3 3 3 3 2 2 1
15 Theresa 58 2 2 2 2 2 2 2 2 2 1 2 2 1 2 2 2 2 1 2 2 3 2 45 154 187 11.47400 10 3.4 6.5 103 24 0.5 0.6 28 30 3.1 3 2 1 1 1 1
16 Vadugunathan 49 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 2 1 2 3 2 30 145 168 116300 5 3.9 8.2 159 28 0.8 0.9 36 38 4 1 1 1 1 1 1
17 Ganesan 60 1 1 1 1 2 2 2 1 1 2 1 2 2 1 1 1 1 2 1 1 3 2 50 145 126 1149800 10 4.2 6.9 124 24 0.6 0.8 27 26 4.7 3 3 3 2 3 2
18 Hemalatha 58 2 1 2 2 2 2 2 2 2 1 2 2 2 2 2 1 2 2 2 2 3 2 45 136 182 10.8 7500 8 3.6 8.2 187 24 0.8 0.7 32 34 5.3 1 3 1 1 1 2
19 Kanakaraj 68 1 0 2 2 2 2 2 2 1 2 2 2 1 2 2 2 2 1 2 2 2 2 34 124 156 9.8 4500 12 4.5 7 10124 0.5 0.6 25 28 3.1 1 2 1 1 1 1
20 Leelavathy 63 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 2 2 1 3 3 45 186 199 11.44900 5 3.8 7.8 145 28 0.7 0.6 21 29 5.3 1 1 1 1 1 1
21 Madusudhana Rao 65 1 2 2 2 2 2 2 1 1 1 2 2 2 1 2 1 2 2 1 1 3 3 42 120 140 11.48500 5 3.2 7.1 87 21 0.5 0.6 24 26 4.2 3 3 3 1 1 1
22 Marichamy 49 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 1 2 46 124 185 11.54500 5 3.6 6.8 89 24 0.8 0.6 24 28 3.6 3 3 3 1 1 1
23 Mariyappan 60 1 2 2 2 2 2 2 2 2 2 1 2 2 2 1 1 1 2 1 2 1 2 34 145 158 11.26500 7 3.8 6.8 86 35 0.7 0.8 25 30 4.7 1 1 2 1 2 1
24 Premkumar 48 1 0 2 2 2 2 2 2 2 1 2 2 1 2 2 1 2 2 1 2 3 3 45 142 157 11.68900 8 3.5 7.2 10124 0.5 0.4 24 24 4.8 1 3 3 1 2 2
25 Robert 55 1 1 1 2 1 2 2 2 1 2 2 2 1 2 2 2 2 1 1 1 3 3 47 124 156 10.8 6500 7 4.2 6.3 104 25 0.6 0.6 80 120 4 3 3 3 1 2 1
26 Siromani 50 1 2 2 2 2 2 2 2 2 2 1 2 1 1 2 1 2 2 2 1 3 2 41 157 145 11.59840 5 3.6 7.1 88 26 0.8 0.6 24 36 4.3 3 2 1 1 1 1
27 Subbaiah 63 1 2 2 2 2 2 2 1 2 1 1 2 1 2 1 2 2 2 1 1 2 2 55 180 164 11.48500 12 3.5 7.2 87 25 0.5 0.8 84 96 2.9 3 3 3 3 3 2
28 Velvizhi 38 2 2 2 2 2 2 2 1 1 1 2 2 1 2 2 2 1 2 2 2 2 2 54 145 187 10.2 4850 10 3.5 7.2 98 24 0.8 0.7 87 102 3 1 1 3 2 3 2
29 Vijayakumar 44 1 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 1 2 3 47 142 168 11.48400 8 3.7 7 84 21 0.6 0.6 28 32 4.9 3 3 1 1 1 1
30 Abdul Rahman 59 1 1 2 2 2 2 2 2 2 1 1 2 2 2 2 1 1 2 1 2 3 3 45 124 169 11.15200 7 3.1 7.1 99 25 0.5 0.8 40 40 4.7 3 3 1 1 1 1
31 Amsaveni Selvaraj 63 1 1 1 1 1 2 2 2 2 1 2 2 1 1 2 2 1 2 2 2 2 1 40 145 165 8.6 9800 12 3.6 8.4 154 25 0.9 0.5 84 112 2.9 3 3 1 3 1 2
32 Arumugam 70 1 2 2 2 2 2 2 2 1 1 2 2 1 2 1 2 1 2 1 1 2 2 35 180 160 10.4 4560 10 3.6 7.2 102 25 0.4 0.5 24 26 3.3 1 3 3 2 2 2
33 Ashok Kumar 45 1 0 2 2 2 2 2 2 1 2 2 2 2 1 1 2 2 2 2 1 3 3 45 148 175 10.5 6800 12 3.4 7 104 24 0.5 0.6 65 84 4.7 1 2 3 1 1 1
34 Bhaskaran 60 1 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 1 1 1 3 3 40 152 160 10.5 7500 5 3 6.9 88 24 0.6 0.5 28 32 4.6 1 1 2 1 1 1
35 Ganesan 55 1 0 2 2 2 2 2 2 2 1 1 2 2 2 2 2 1 2 2 1 3 3 54 110180 11.44900 10 2.8 7.2 98 28 0.5 0.6 44 52 5 1 2 2 1 1 1
36 Girija 69 2 2 2 2 2 2 2 2 1 1 2 2 1 1 2 2 2 2 2 2 2 1 51 175 142 10.5 7540 12 2.5 7 10123 0.5 0.6 44 68 4.6 1 2 1 1 2 1
37 Hulasi Bai 70 2 1 2 2 1 2 2 1 1 1 1 1 1 2 1 1 1 2 2 2 2 2 47 157 168 8.5 6830 8 2.9 8.2 187 25 0.8 0.9 65 80 3.3 2 3 3 1 3 3
38 Kuupu Rao 65 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 2 2 1 3 3 30 195 ## 11.85830 8 3.6 7.2 124 26 0.6 0.9 42 45 3.7 3 3 3 1 3 1
39 Mahaboor Basha 37 2 2 2 2 2 2 2 2 1 1 2 2 1 2 2 2 2 2 2 2 2 2 40 120 157 10.2 7600 10 3.4 7.1 100 28 0.7 0.9 34 38 3.5 3 3 3 3 2 1
40 Sabapathy 64 1 2 2 2 2 2 2 2 2 1 1 2 2 2 1 1 2 2 1 1 2 2 45 150 180 10.5 8600 12 3.8 7.2 120 24 0.6 0.8 75 85 4 1 3 1 1 2 1
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41 Samsudeen 45 1 2 2 2 2 2 2 2 2 2 1 1 2 2 2 1 2 2 2 1 3 3 40 150 140 11.15900 6 3.4 6.8 85 36 0.4 0.9 40 85 5 1 3 1 1 1 1
42 Saroja 65 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 1 2 2 2 2 3 47 120 ## 9.8 6200 20 3.8 7.2 140 25 0.6 0.8 84 98 5 1 3 3 2 1 1
43 Vijayabaskar 70 1 2 2 2 2 2 2 2 1 1 2 2 1 1 2 2 2 2 2 1 3 3 45 15 124 11.23500 10 3.6 6.5 120 25 0.6 0.7 58 64 4.6 1 1 3 1 1 1
44 Bala Thandayudham 47 1 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 1 1 2 3 35 100 150 11.26800 12 2.8 6.5 96 28 0.8 0.8 28 30 4.7 1 1 1 1 1 1
45 Dasari Devasree 43 2 2 2 2 2 2 2 2 1 1 2 2 2 1 2 2 2 2 2 2 3 3 40 120 155 10.8 8600 5 2.9 7 85 20 0.9 0.9 30 35 4.6 2 2 1 1 1 1
46 Gowri Shankar 52 1 0 2 2 2 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 3 3 45 175 190 10.6 5800 6 2.6 7.6 138 22 0.9 0.9 30 35 4.3 3 1 3 1 1 1
47 Durai Rajan 77 1 1 2 2 2 2 2 2 1 1 1 2 1 2 2 1 2 2 1 2 1 2 45 135 150 9.8 6500 15 3.5 8 158 20 0.6 0.9 23 22 3.3 3 3 3 3 2 2
48 Hemavathy 59 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 1 2 2 2 2 2 50 130 150 10.9 7500 5 3.1 7 10128 0.6 0.6 28 32 4.6 1 1 2 1 1 1
49 Josephine 62 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 2 2 2 3 40 120 115 11.68500 10 3.6 7.5 96 21 0.6 0.9 28 32 5.1 3 3 3 1 1 1
50 Krishnamurthy 69 1 2 2 2 2 2 2 2 1 1 2 2 2 1 2 1 2 1 2 2 2 3 40 140 150 11.15600 10 3.8 7 98 20 0.8 0.9 30 35 4 3 3 3 1 1 1
51 Kundanrai Malhotra 81 2 1 2 2 1 2 2 1 1 2 2 2 1 2 2 1 2 1 2 2 2 1 45 135 128 9.8 7500 22 3.6 7.1 86 26 0.8 0.6 24 32 3.1 2 2 3 3 3 2
52 Meenakshiamma 52 2 2 2 2 2 2 2 2 1 1 2 2 2 1 2 2 1 2 2 2 2 2 45 95 130 10.16800 12 2.8 72 98 22 0.6 0.9 25 30 5.4 1 1 2 1 1 1
53 Murugan 48 1 2 2 2 1 1 2 2 1 1 2 2 2 2 1 2 2 2 1 1 2 2 43 117180 9.6 6800 15 2.6 7.1 85 29 0.6 0.9 30 35 4.7 3 3 3 1 1 1
54 Nagaraja Rao 67 1 2 2 2 2 2 2 2 1 1 1 2 1 1 2 1 2 1 2 1 3 3 42 158 140 10.8 8600 8 3.8 7 85 28 0.7 0.6 25 35 5.3 1 1 1 1 1 1
55 Radhakrishnan 56 1 1 1 2 1 2 2 2 1 1 2 2 1 2 2 2 2 1 1 2 2 2 45 145 180 10.6 6500 15 2.8 7.8 152 25 0.6 0.6 28 32 4 3 3 3 2 2 1
56 Rajamani 50 1 2 2 2 2 2 2 2 1 1 1 2 2 2 2 1 2 2 2 2 3 3 45 140 160 11.66800 10 3.8 7.6 85 25 0.6 0.8 20 25 5.1 3 3 1 1 1 1
57 Ramakrishnaiah 73 1 2 2 2 1 2 2 2 1 2 2 2 2 2 2 2 2 1 2 2 3 2 35 125 180 11.85800 5 1.8 6.5 80 24 0.6 0.6 35 30 3.3 3 3 3 1 1 1
58 Somasundaram 57 1 1 1 1 2 2 2 2 1 2 2 2 1 2 2 2 2 1 1 2 2 2 40 140 190 10.8 8600 5 3.6 8 85 28 0.6 0.6 30 35 3.5 3 1 1 1 3 1
59 Srinvasa Reddy 30 1 1 1 1 2 2 2 2 1 1 2 2 2 2 2 2 1 1 1 2 1 1 40 178 ## 10.8 8600 5 1.8 6.8 96 28 0.8 0.6 28 32 3.1 1 1 1 3 3 1
60 Subramaniyam 47 1 2 2 2 2 2 2 2 1 2 1 2 2 2 2 1 1 2 1 2 3 2 30 150 155 115800 5 3.6 6.8 10128 0.7 0.7 35 32 4.4 3 1 3 1 1 1
61 Yasodha 62 2 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 1 2 2 2 40 120 180 9.8 8600 5 3.2 7.1 102 24 0.5 0.6 38 35 4.1 1 2 2 1 1 1
62 Sabapathy 45 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 3 2 45 124 159 116500 5 3.6 7 85 25 0.6 0.9 48 46 4.6 1 1 2 1 1 1
63 Anajaneyalu 48 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 2 1 1 3 2 40 135 140 11.24500 8 3.5 6.8 89 25 0.6 0.9 40 35 4 1 2 1 1 1 1
64 Thangaraj 65 1 2 2 2 2 1 2 2 1 1 2 2 2 2 1 1 1 2 1 1 2 1 42 112130 11.48400 7 4.1 7.2 105 24 0.8 0.5 54 65 4.7 1 2 1 1 2 1
65 Fathima Mary 72 2 2 2 2 2 2 2 2 1 1 2 2 1 2 2 2 2 2 2 2 1 2 56 120 114 10.5 7500 22 3.4 7.9 120 21 0.5 0.6 25 40 4.3 1 2 3 2 3 1
66 Mathiazhagan 51 1 2 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 2 1 2 3 2 40 100 140 11.56500 8 3.6 6.5 11225 0.6 0.8 42 40 4 1 2 1 1 1 1
67 Sivashankar 56 1 2 2 2 2 2 2 2 2 1 1 2 2 2 1 2 2 2 1 1 2 1 35 120 114 10.8 8500 4 3.5 6.5 98 25 0.6 0.9 58 68 4.2 1 3 2 1 3 1
68 Tamil Selvi 65 2 1 2 2 2 2 2 2 1 1 2 2 1 2 2 2 1 2 2 2 2 1 35 98 124 11.37500 8 3.1 7.4 98 24 0.5 0.6 40 43 3.6 1 3 3 2 3 1
69 Mohan Krishnan 35 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 3 3 48 112145 11.87600 4 3.6 7.1 91 21 0.5 0.6 40 35 4.5 1 2 1 1 1 1
70 Velayutham 54 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 2 2 1 3 3 45 124 185 10.5 8400 8 3.9 7.5 109 24 0.5 0.7 35 39 4.6 1 1 2 1 1 1
71 Mythiliraghavan 40 2 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 2 2 2 3 3 40 120 142 10.8 8300 5 3.6 7 85 25 0.6 0.4 80 90 5 1 3 2 1 1 1
72 Sudhakar Reddy 62 1 2 2 2 2 2 2 2 1 1 2 2 1 1 1 2 2 2 1 1 2 2 42 115124 11.54500 9 3.9 7.1 96 25 0.6 0.5 28 32 3.6 1 3 3 1 3 3
73 Muniraghavan 54 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 1 2 3 3 35 120 135 11.65400 5 3.1 6.8 94 24 0.9 0.8 23 28 3.9 2 2 2 1 1 1
74 Thirugnanasambadam 48 1 2 2 2 2 2 2 2 1 2 2 2 1 1 2 1 1 2 1 2 2 2 39 120 152 11.86500 8 3.8 6.5 94 28 0.9 0.6 40 35 4.6 1 2 2 1 1 1
75 Sampathi 42 2 0 2 2 1 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 3 2 36 114125 10.8 7400 5 3.2 6.8 10125 0.6 0.5 40 60 4.9 2 1 3 1 1 1
76 Leelavathi Bai 65 2 2 2 2 1 2 2 2 2 1 2 2 1 2 2 2 1 2 2 2 3 2 36 145 120 10.6 6500 12 3.4 6.5 104 25 0.8 0.4 24 28 3.3 2 3 1 2 3 1
77 Thayumanavan 45 1 2 2 2 2 2 2 2 1 2 2 2 2 1 2 2 2 2 2 2 2 2 35 124 165 11.55200 8 3.4 6.5 102 28 0.6 0.9 30 34 3.3 2 1 3 1 1 1
78 Alamelu Mangai 65 2 2 1 2 2 2 2 2 2 1 2 2 1 1 2 2 1 2 2 2 2 2 45 132 124 10.5 4500 10 3.5 6.8 98 24 0.6 0.5 45 42 3 2 2 2 2 3 2
79 Jayamani 55 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 3 3 42 110 110 11.24500 12 3.5 6.9 99 25 0.4 0.6 24 26 3.3 2 2 2 1 1 1
80 Boopalan 45 1 2 2 2 2 2 2 2 1 2 2 2 1 1 2 2 2 1 1 2 3 3 48 110142 11.48500 6 3.5 7.6 140 25 0.5 0.6 40 35 4.3 1 2 1 1 1 1
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81 Murali 45 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 1 3 2 42 105 120 11.86500 5 3.2 6.8 96 24 0.6 0.9 65 85 4.6 1 2 1 1 1 1
82 Prathap Reddy 56 1 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 1 2 2 1 3 2 56 114135 11.56500 8 3.6 6.8 87 26 0.8 0.5 24 26 5 1 3 1 1 1 1
83 Chandrasekaran 58 1 2 2 2 2 2 2 2 2 1 2 2 2 1 1 2 2 2 1 2 2 2 45 120 153 11.5 560 5 3.6 7.1 86 25 0.5 0.6 45 40 3.3 1 3 2 1 3 1
84 Hiaun Aung 42 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 3 3 45 125 134 114520 8 3.4 6.5 88 25 0.6 0.5 24 28 3.5 1 2 1 1 1 1
85 Malini Raman 74 2 1 2 2 2 2 2 2 2 1 2 2 2 2 1 2 1 2 2 2 2 2 41 154 123 9.8 6500 12 3.2 7.2 86 25 0.5 0.6 35 30 3.4 2 2 1 2 2 1
86 Narasimha Samy 54 1 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 1 3 2 41 99 121 11.46500 20 3.6 7.1 87 25 0.6 0.9 25 29 4.6 1 1 2 1 1 1
87 Srinivasalu 60 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 1 2 2 2 2 3 3 48 101 121 11.59800 5 3.1 7.2 86 24 0.7 0.4 24 54 4.7 1 2 1 1 1 1
88 Mariam 48 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 1 2 2 2 2 3 45 98 124 10.16500 8 3.4 7.2 11024 0.6 0.9 87 89 4 2 2 1 1 1 1
89 Rajagopal 81 1 2 2 2 2 2 2 2 1 2 2 2 1 2 1 1 2 1 1 2 2 2 51 120 98 10.6 7540 6 3.1 7.2 99 25 0.7 0.6 65 69 4.6 1 1 2 1 2 1
90 Prabakaran 54 1 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 2 2 2 35 112145 9.8 6500 8 3.5 8 157 25 0.4 0.5 25 28 4.7 1 1 2 1 1 1
91 Pichaimuthu 75 1 2 2 2 2 2 2 2 2 1 2 2 1 2 1 2 2 2 2 1 2 3 45 97 114 10.8 4620 10 3.6 6.8 100 25 0.8 0.7 80 90 3.1 3 3 3 2 2 1
92 Sugunamei 50 2 1 2 2 2 2 2 2 1 2 2 2 2 2 1 2 2 2 1 2 3 3 45 142 121 10.5 4520 10 3.8 8.2 124 29 0.5 0.6 40 42 3.1 1 1 3 1 2 1
93 Ganesan 54 1 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 3 3 54 102 121 11.89864 5 3.9 6.5 98 24 0.8 0.6 24 28 4 1 2 1 1 1 1
94 Shafi Ahmed 55 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 45 100 120 11.96500 5 3.5 6.5 98 25 0.6 0.5 35 36 4.3 2 2 1 1 1 1
95 Mohan 45 1 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 1 2 1 2 3 3 45 132 100 11.55632 5 3.2 6.8 11025 0.6 0.5 80 45 4.7 2 1 2 1 1 1
96 Ignatius Mary 68 2 2 2 2 2 2 2 2 2 1 2 2 1 2 2 2 2 2 2 2 3 2 41 100 100 10.4 7430 8 3.9 6.9 102 25 0.6 0.9 40 36 3.3 2 2 1 1 3 1
97 Balambal 40 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 3 3 54 98 100 118540 8 4 6.8 98 24 0.6 0.7 80 45 4.2 1 2 2 1 1 1
98 Rajeshwari 54 2 2 2 2 2 2 2 2 1 2 2 2 1 1 1 2 2 2 2 2 2 2 48 100 132 11.56800 12 3.9 6.8 87 24 0.6 0.5 40 42 3.3 2 1 3 2 3 1
99 Radha 40 2 1 1 2 2 2 2 2 1 2 2 2 2 2 1 2 2 1 2 1 2 2 35 102 120 9.8 7800 12 3.4 7 11028 0.5 0.6 24 28 4.3 1 1 2 2 1 1
100 Kalyani 56 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 3 2 41 102 102 10.5 4562 5 3.5 6.5 98 25 0.6 0.7 40 45 4.3 1 1 2 1 1 1
101Amritha 48 2 2 2 2 1 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 3 2 41 102 142 116500 5 2.8 7.1 85 24 0.6 0.6 25 35 3.8 2 1 1 1 1 1
102 Soundarya 65 2 2 2 2 2 2 2 2 1 2 2 2 1 1 2 2 1 2 2 2 2 2 48 98 124 10.8 7500 12 3.5 8.5 145 29 0.8 0.6 28 32 3.5 2 2 1 2 1 1
103 Dinesh 42 1 2 2 2 2 2 2 2 2 1 2 2 1 2 2 2 2 2 2 1 3 3 54 120 145 11.47500 8 3.6 7 104 32 0.8 0.6 32 36 4 1 3 1 1 1 1
104 Karthick 54 1 1 1 2 2 2 2 2 2 1 2 2 2 2 1 2 2 2 1 1 2 3 48 124 135 11.26500 7 3.8 7.1 109 30 0.8 0.5 40 40 3.3 1 3 2 1 3 1
105 Subash 67 1 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 2 2 2 2 3 3 41 107 129 11.64500 9 3.5 7.2 104 28 0.4 0.5 44 48 3.9 2 1 2 1 1 1
106 Kuppammal 54 2 2 2 2 1 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 3 2 51 130 167 10.6 7400 8 3.6 6.5 100 24 0.8 0.6 28 32 4 1 2 1 1 2 1
107 Bhuvana 60 2 2 2 2 2 2 2 2 1 2 2 2 1 2 2 2 1 2 2 2 2 2 50 145 165 9.8 6500 12 3.8 7.4 102 20 0.5 0.6 28 32 3.4 2 2 1 1 3 1
108 Shankar 62 1 0 2 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 1 3 2 45 124 168 11.87500 12 3.6 7.2 99 24 0.5 0.8 36 40 3.9 2 1 2 1 1 1
109 Hemnath 58 1 2 2 2 1 2 2 2 2 1 2 2 2 2 2 2 2 2 2 1 3 3 48 135 146 11.44500 8 3.5 7.4 98 25 0.5 0.6 80 85 4 2 1 1 1 1 1
110Sundarraj 40 1 1 2 2 2 2 2 2 1 2 2 2 2 1 1 2 2 2 1 1 2 2 44 125 145 10.8 6500 20 3.8 8 140 25 0.6 0.4 40 36 3.1 1 3 2 1 3 2
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KEY 
DM Diabetes Mellitus SOB Shortness of Breath 
HT Hypertension HDL High density lipoprotein 
IHD Ischemic Heart Disease LDL Low density lipoprotein 
PVD Peripheral Vascular Disease TGL Triglycerides 
BMI Body Mass Index Hb Hemoglobin 
FBS Fasting Blood Sugar TC Total Count 
BUN Blood Urea Nitrogen ESR Erythrocyte Sedimentation Rate 
SGOT Serum glutamic oxaloacetic transaminase SGPT Serum glutamic pyruvate transaminase 
RCA Right Coronary Artery Celiac Celiac Axis 
LAD Left Anterior Descending Artery SMA Superior Mesenteric Artery 
LCX Left Circumflex Artery IMA Inferior Mesenteric Artery 
 
